Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 5.020
- -0.315-5.90%
Close Dec 20 16:00 ET
- 5.020
- 0.0000.00%
Post 20:01 ET
15.19MMarket Cap-0.04P/E (TTM)
5.455High5.020Low28.97KVolume5.050Open5.335Pre Close147.97KTurnover1.27%Turnover RatioLossP/E (Static)3.03MShares27.50052wk High-7.47P/B11.46MFloat Cap4.06052wk Low--Dividend TTM2.28MShs Float1751062.500Historical High--Div YieldTTM8.15%Amplitude4.060Historical Low5.108Avg Price1Lot Size
Traws Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -78.57%5.41M | -43.20%16.89M | -52.10%16.39M | -46.28%20.82M | -46.28%20.82M | -40.76%25.24M | -36.11%29.73M | -32.59%34.22M | -29.62%38.76M | -29.62%38.76M |
| -Cash and cash equivalents | -78.57%5.41M | -43.20%16.89M | -52.10%16.39M | -46.28%20.82M | -46.28%20.82M | -40.76%25.24M | -36.11%29.73M | -32.59%34.22M | -29.62%38.76M | -29.62%38.76M |
| Receivables | 11,683.33%2.12M | 5.88%18K | 5.88%18K | -37.93%18K | -37.93%18K | -35.71%18K | -39.29%17K | -37.04%17K | 3.57%29K | 3.57%29K |
| -Accounts receivable | 11,683.33%2.12M | 5.88%18K | 5.88%18K | -37.93%18K | -37.93%18K | -35.71%18K | -39.29%17K | -37.04%17K | 3.57%29K | 3.57%29K |
| Prepaid assets | -27.73%1.05M | 169.09%1.18M | 101.91%1.48M | 172.55%1.42M | 172.55%1.42M | 79.18%1.45M | -62.26%440K | 164.98%734K | 75.42%521K | 75.42%521K |
| Other current assets | 14.52%347K | 120.83%583K | 286.76%263K | 902.50%401K | 902.50%401K | 0.00%303K | -13.73%264K | -77.78%68K | 14.29%40K | 14.29%40K |
| Total current assets | -66.97%8.92M | -38.68%18.67M | -48.19%18.15M | -42.41%22.66M | -42.41%22.66M | -38.26%27.01M | -36.61%30.45M | -31.80%35.04M | -29.01%39.35M | -29.01%39.35M |
| Non current assets | ||||||||||
| Net PPE | -53.85%12K | -17.65%14K | -14.29%18K | -8.33%22K | -8.33%22K | -7.14%26K | -45.16%17K | -40.00%21K | -36.84%24K | -36.84%24K |
| -Gross PPE | 0.00%84K | 20.00%84K | 20.00%84K | 20.00%84K | 20.00%84K | 20.00%84K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K |
| -Accumulated depreciation | -24.14%-72K | -32.08%-70K | -34.69%-66K | -34.78%-62K | -34.78%-62K | -38.10%-58K | -35.90%-53K | -40.00%-49K | -43.75%-46K | -43.75%-46K |
| Other non current assets | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | -90.00%1K | -90.00%1K | -90.00%1K | -90.00%1K |
| Total non current assets | -51.85%13K | -16.67%15K | -13.64%19K | -8.00%23K | -8.00%23K | -6.90%27K | -56.10%18K | -51.11%22K | -47.92%25K | -47.92%25K |
| Total assets | -66.95%8.94M | -38.67%18.69M | -48.17%18.17M | -42.39%22.68M | -42.39%22.68M | -38.24%27.04M | -36.62%30.47M | -31.82%35.06M | -29.03%39.37M | -29.03%39.37M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -11.00%5.47M | 21.75%6.17M | 34.15%6.57M | 45.57%5.62M | 45.57%5.62M | 63.51%6.15M | 68.86%5.07M | 56.82%4.9M | 40.01%3.86M | 40.01%3.86M |
| -accounts payable | -11.00%5.47M | 21.75%6.17M | 34.15%6.57M | 45.57%5.62M | 45.57%5.62M | 63.51%6.15M | 68.86%5.07M | 56.82%4.9M | 40.01%3.86M | 40.01%3.86M |
| Current accrued expenses | -20.48%1.95M | 18.73%3.12M | -36.24%2.17M | -14.42%2.37M | -14.42%2.37M | 4.49%2.45M | 20.67%2.63M | 81.79%3.41M | 44.80%2.77M | 44.80%2.77M |
| Current deferred liabilities | 0.00%226K | 0.44%227K | 0.00%226K | 0.00%226K | 0.00%226K | 0.00%226K | 0.00%226K | 0.00%226K | 0.00%226K | 0.00%226K |
| Current liabilities | -13.71%8.35M | 14.35%9.91M | 2.15%9.42M | 14.59%9.22M | 14.59%9.22M | 31.87%9.67M | 34.15%8.67M | 55.08%9.22M | 31.58%8.05M | 31.58%8.05M |
| Non current liabilities | ||||||||||
| Non current deferred liabilities | -7.94%2.62M | -7.82%2.68M | -7.63%2.74M | -7.49%2.79M | -7.49%2.79M | -7.35%2.85M | -7.22%2.9M | -7.09%2.96M | -6.97%3.02M | -6.97%3.02M |
| Preferred securities outside stock equity | ---- | --111.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | -7.94%2.62M | 3,835.81%114.3M | -7.63%2.74M | -7.49%2.79M | -7.49%2.79M | -7.35%2.85M | -7.22%2.9M | -7.09%2.96M | -6.97%3.02M | -6.97%3.02M |
| Total liabilities | -12.40%10.97M | 973.52%124.21M | -0.23%12.16M | 8.57%12.01M | 8.57%12.01M | 20.29%12.52M | 20.65%11.57M | 33.39%12.19M | 18.22%11.06M | 18.22%11.06M |
| Shareholders'equity | ||||||||||
| Share capital | -85.71%30K | 20.48%253K | 0.48%211K | 0.48%210K | 0.48%210K | 0.48%210K | 0.48%210K | 0.48%210K | 0.00%209K | 0.00%209K |
| -common stock | -85.71%30K | 20.48%253K | 0.48%211K | 0.48%210K | 0.48%210K | 0.48%210K | 0.48%210K | 0.48%210K | 0.00%209K | 0.00%209K |
| -Preferred stock | --0 | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -29.43%-619.23M | -28.93%-610.76M | -3.87%-487.61M | -4.09%-482.63M | -4.09%-482.63M | -4.40%-478.45M | -4.60%-473.71M | -4.59%-469.46M | -4.26%-463.68M | -4.26%-463.68M |
| Paid-in capital | 25.25%617.2M | 2.56%505.02M | 0.26%493.45M | 0.26%493.12M | 0.26%493.12M | 0.26%492.78M | 0.25%492.42M | 0.25%492.15M | 0.24%491.82M | 0.24%491.82M |
| Gains losses not affecting retained earnings | -10.00%-33K | -17.86%-33K | -11.11%-30K | 30.30%-23K | 30.30%-23K | 50.82%-30K | 31.71%-28K | -28.57%-27K | -135.71%-33K | -135.71%-33K |
| Total stockholders'equity | -114.00%-2.03M | -658.37%-105.52M | -73.71%6.02M | -62.30%10.67M | -62.30%10.67M | -56.50%14.52M | -50.89%18.9M | -45.90%22.88M | -38.62%28.31M | -38.62%28.31M |
| Total equity | -114.00%-2.03M | -658.37%-105.52M | -73.71%6.02M | -62.30%10.67M | -62.30%10.67M | -56.50%14.52M | -50.89%18.9M | -45.90%22.88M | -38.62%28.31M | -38.62%28.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |